INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Scope & Guideline
Transforming drug therapy with scholarly excellence.
Introduction
Aims and Scopes
- Clinical Pharmacokinetics and Pharmacodynamics:
The journal publishes research on the absorption, distribution, metabolism, and excretion (ADME) of drugs, as well as their pharmacological effects, highlighting studies that explore how various factors influence drug behavior in the body. - Therapeutic Drug Monitoring and Optimization:
There is a strong emphasis on studies that assess therapeutic drug monitoring (TDM) practices to optimize medication efficacy and minimize toxicity, particularly in vulnerable populations such as those with renal impairment or undergoing chemotherapy. - Pharmacovigilance and Drug Safety:
The journal includes articles on post-marketing surveillance, adverse drug reactions, and safety profiles of medications, underscoring the importance of pharmacovigilance in clinical practice. - Bioequivalence and Drug Formulation Studies:
Research on the bioequivalence of drug formulations and their implications for therapeutic efficacy is a core area, reflecting the journal's commitment to ensuring that generic and branded medications provide similar therapeutic outcomes. - Impact of Comorbidities on Pharmacotherapy:
The journal frequently publishes studies examining how comorbid conditions affect drug therapy, especially in populations with complex health needs, such as the elderly or those with chronic diseases. - Network Pharmacology and Traditional Medicine:
Emerging themes include the use of network pharmacology to understand drug interactions and the efficacy of traditional medicine, particularly in the context of integrative approaches to therapy.
Trending and Emerging
- COVID-19 Treatment and Drug Interactions:
A significant increase in research related to COVID-19, including drug interactions and treatment efficacy, underscores the pandemic's impact on clinical pharmacology and the urgency for effective therapeutic strategies. - Real-World Evidence and Patient-Centered Research:
There is a growing emphasis on real-world evidence studies that assess drug efficacy and safety in diverse patient populations, moving beyond controlled clinical trial settings to understand practical therapeutic outcomes. - Network Pharmacology and AI in Drug Research:
The utilization of network pharmacology and artificial intelligence to analyze drug interactions and therapeutic targets is gaining traction, indicating a modern approach to drug discovery and personalized medicine. - Polypharmacy and Drug-Drug Interactions:
Research focused on polypharmacy, particularly in geriatric populations, is on the rise, reflecting concerns about adverse drug interactions and the need for careful medication management. - Therapeutic Strategies for Chronic Diseases:
Emerging studies are increasingly addressing therapeutic strategies for managing chronic diseases, such as diabetes and cardiovascular conditions, highlighting the need for tailored pharmacotherapy in these populations.
Declining or Waning
- Basic Pharmacology Studies:
There appears to be a waning interest in basic pharmacological studies that do not directly translate into clinical applications, as the journal increasingly prioritizes research with immediate clinical relevance. - Non-Clinical Trial Research:
The publication of studies that focus solely on non-clinical trial methodologies or theoretical frameworks has decreased, indicating a preference for clinical trial data and real-world evidence. - Historical Drug Use Studies:
Research focusing on historical trends in drug use or retrospective analyses that do not incorporate current clinical guidelines or practices is less frequently featured, suggesting a pivot towards more contemporary, applicable research. - Single-Agent Pharmacotherapy:
There is a noticeable decline in studies examining the effects of single-agent therapies, as the journal increasingly highlights multi-drug regimens and combination therapies that reflect real-world clinical practice. - Pharmacogenomics:
Although pharmacogenomics remains important, there has been a relative decrease in the number of studies dedicated solely to genetic factors influencing drug response, as more integrated approaches are favored.
Similar Journals
JOURNAL OF CLINICAL PHARMACOLOGY
Pioneering Knowledge in Medical PharmacologyWelcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.
PHARMACIA
Elevating research in pharmaceutical sciences to global heights.PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.
ACTA POLONIAE PHARMACEUTICA
Innovating Drug Development Through Peer-reviewed ResearchACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.
THERAPEUTIC DRUG MONITORING
Elevating Standards in Drug Therapy OptimizationTHERAPEUTIC DRUG MONITORING, published by Lippincott Williams & Wilkins, is a prestigious journal that focuses on the critical area of pharmacology, with a specific emphasis on the therapeutic optimization of drug therapy. With an ISSN of 0163-4356 and an E-ISSN of 1536-3694, this peer-reviewed journal has been contributing valuable research and insights to the field since its inception in 1979. As of 2023, it holds a Q2 classification in the Pharmacology category, indicating its prominent role in advancing pharmaceutical sciences. The journal aims to enhance understanding of drug effectiveness and safety through rigorous studies on drug monitoring and individualized therapy, making it an essential resource for researchers, healthcare professionals, and students dedicated to improving patient care. With its solid standing reflected in Scopus rankings, including a rank of #103 in medical pharmacology and a 62nd percentile, THERAPEUTIC DRUG MONITORING continues to be a vital publication for those aiming to contribute to and stay informed about the latest developments in the field.
ACTA PHARMACOLOGICA SINICA
Pioneering Insights in Medical PharmacologyACTA PHARMACOLOGICA SINICA is a premier journal in the field of pharmacology, published by the esteemed Nature Publishing Group. With a strong history since its inception in 1980, this journal is recognized for its impactful contributions to the fields of medicine and pharmacology, consistently securing a Q1 ranking in multiple relevant categories, including Pharmacology (Medical). Drawing on a robust international readership, it ranks impressively at #8 out of 272 in the specialty of Medical Pharmacology, placing it in the top 97th percentile according to Scopus data. Although currently not an open-access publication, ACTA PHARMACOLOGICA SINICA remains a vital resource for researchers, professionals, and students seeking to advance their understanding of pharmacological sciences. Its commitment to disseminating high-quality research underscores its significance in fostering innovation and exploration in the medical landscape.
Clinical Pharmacology-Advances and Applications
Catalyzing Collaboration for Pharmacological ExcellenceClinical Pharmacology-Advances and Applications is a premier open access journal published by DOVE MEDICAL PRESS LTD, based in New Zealand. Since its establishment in 2009, the journal has been dedicated to advancing the field of pharmacology by disseminating innovative research and applications related to medication therapy and patient outcomes. With its notable impact factor and current ranking within the top percentile of pharmacology journals, it provides an invaluable platform for researchers, healthcare professionals, and students to share knowledge and foster collaboration. The journal's content spans a wide range of topics, ensuring coverage of both fundamental and emerging areas in medical pharmacology. As of 2023, it holds a strong position in the Q2 quartile, underscoring its relevance and influence within the scientific community. Authors and readers alike benefit from its open access model, which ensures that critical findings are widely accessible, thereby enhancing the pace of discovery and application in clinical settings.
Advances in Pharmacological and Pharmaceutical Sciences
Exploring Innovations in Pharmaceutical Research.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
INDIAN JOURNAL OF PHARMACOLOGY
Advancing pharmacological knowledge for a healthier tomorrow.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Exploring the intersection of fundamental research and clinical application.FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.
BRITISH JOURNAL OF PHARMACOLOGY
Exploring the frontiers of pharmacology and toxicology.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.